Correlation Between Cytodyn and Coya Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Cytodyn and Coya Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cytodyn and Coya Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cytodyn and Coya Therapeutics, Common, you can compare the effects of market volatilities on Cytodyn and Coya Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cytodyn with a short position of Coya Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cytodyn and Coya Therapeutics,.

Diversification Opportunities for Cytodyn and Coya Therapeutics,

-0.09

Correlation Coefficient

Cytodyn  Coya Therapeutics,

Good diversification

The 3 months correlation between Cytodyn and Coya is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Cytodyn and Coya Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coya Therapeutics, Common and Cytodyn is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cytodyn are associated (or correlated) with Coya Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coya Therapeutics, Common has no effect on the direction of Cytodyn i.e., Cytodyn and Coya Therapeutics, go up and down completely randomly.

Pair Corralation between Cytodyn and Coya Therapeutics,

Given the investment horizon of 90 days Cytodyn is expected to generate 1.29 times more return on investment than Coya Therapeutics,. However, Cytodyn is 1.29 times more volatile than Coya Therapeutics, Common. It trades about -0.08 of its potential returns per unit of risk. Coya Therapeutics, Common is currently generating about -0.22 per unit of risk. If you would invest  12.00  in Cytodyn on September 9, 2024 and sell it today you would lose (1.00) from holding Cytodyn or give up 8.33% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cytodyn  vs.  Coya Therapeutics, Common

Cytodyn

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cytodyn has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Coya Therapeutics, Common

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Coya Therapeutics, Common are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Coya Therapeutics, sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cytodyn and Coya Therapeutics,

The main advantage of trading using opposite Cytodyn and Coya Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cytodyn position performs unexpectedly, Coya Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coya Therapeutics, will offset losses from the drop in Coya Therapeutics,'s long position.

The idea behind Cytodyn and Coya Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.